Hikma Pharmaceuticals Plc cash flow from financial activities for the twelve months ending December 31, 2024 was $-0.681B, a 25.74% decline year-over-year.
Hikma Pharmaceuticals Plc annual cash flow from financial activities for 2024 was $-0.188B, a 44.21% decline from 2023.
Hikma Pharmaceuticals Plc annual cash flow from financial activities for 2023 was $-0.337B, a 481.03% increase from 2022.
Hikma Pharmaceuticals Plc annual cash flow from financial activities for 2022 was $-0.058B, a 79.79% decline from 2021.